- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Her-2 positive
Total 57773 results
-
Stemline Therapeutics, Inc.RecruitingMetastatic Breast CancerUnited States, Georgia, Brazil, Bulgaria, Romania
-
University of WashingtonNational Cancer Institute (NCI)Active, not recruitingHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Stage III Ovarian Epithelial Cancer | Stage III Ovarian Germ Cell TumorUnited States
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
Institut für Klinische Krebsforschung IKF GmbH...Trium Analysis Online GmbHCompletedStomach Cancer | Gastroesophageal Junction CancerGermany
-
Incyte CorporationHoffmann-La Roche; Genentech, Inc.TerminatedUC (Urothelial Cancer) | NSCLC (Non-small Cell Lung Carcinoma)United States
-
PfizerCompleted
-
Gamze AkayAtaturk UniversityNot yet recruiting
-
Brain In Game scientific-technical serviceUniversity Hospital of Santa Maria, LleidaRecruitingCognitive Impairment, MildSpain
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruitingHip Fractures | Frail Elderly | Robotic RehabilitationItaly
-
Bright Cloud International CorpNational Institute on Aging (NIA); Genesis HealthCare SystemCompleted
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
Neovii BiotechTerminatedBreast Cancer | Breast NeoplasmsBelgium
-
Hoffmann-La RocheCompletedBreast CancerAustralia, Spain, United Kingdom, France, Sweden, Canada, Finland, Italy, Greece, Mexico, Costa Rica, Poland, Brazil, Guatemala, Panama
-
Daiichi Sankyo, Inc.AstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, France, Japan, United Kingdom, Canada
-
Zhejiang Cancer HospitalRecruitingAdvanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment FailedChina
-
Abramson Cancer Center of the University of PennsylvaniaGenentech, Inc.CompletedBreast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterAmgenTerminated
-
Fudan UniversityCompleted
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKline; Genentech, Inc.; Susan G. Komen Breast Cancer FoundationCompleted
-
Meiji Seika Pharma Co., Ltd.Dong-A PharmaceuticalCompleted
-
Damanhour UniversityCompletedGamification | Augmented RealityEgypt
-
Istanbul Demiroglu Bilim UniversityNot yet recruiting
-
Gamze AkayArtvin Coruh UniversityNot yet recruiting
-
Universitätsklinikum Hamburg-EppendorfBoehringer IngelheimTerminated
-
Fudan UniversityNot yet recruitingNon-muscle Invasive Bladder Cancer | HER-2 Protein Overexpression
-
Hebei Medical UniversityUnknown
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End Stage Kidney DiseaseUnited States, Bulgaria, Portugal, Spain, Serbia, Poland
-
Novartis PharmaceuticalsRecruitingBreast CancerGermany, Italy, Belgium, Denmark, France, Spain, Finland, Hungary, Ireland, Czechia, Greece, Canada, Portugal, Slovakia, Bulgaria, Poland, Romania
-
Helse Stavanger HFHelse-Bergen HFEnrolling by invitation
-
Seraphic Group IncUnknownMicrobiomeUnited States
-
Qilu Pharmaceutical Co., Ltd.Completed
-
Stanford UniversityRecruitingVentral Hernia | Abdominoplasty | Panniculus | Flap ReconstructionUnited States
-
Akdeniz UniversityCompletedInfertility | Female Infertility | Frozen-thawed Embryo TransferTurkey
-
Xuanwu Hospital, BeijingPeking University People's Hospital; Chinese PLA General HospitalUnknownCerebrovascular DiseaseChina
-
River 2 Renal Corp.RecruitingAcute Kidney Injury | Hepatorenal SyndromeUnited States
-
University of Rennes 2RecruitingHealthy Young Women | Healthy Young MenFrance
-
University of Rennes 2Completed
-
EMD SeronoCompletedOvarian CancerUnited States
-
National Cancer Center, KoreaActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Hoffmann-La RocheCompletedBreast NeoplasmsFrance, Spain, Sweden, Denmark, Russian Federation, Canada, Germany, United Kingdom, Italy, Turkey, Poland, Switzerland
-
Centro Nacional de Investigaciones Oncologicas...Fundacion CRIS de Investigación para Vencer el CáncerCompletedMetastatic Breast Cancer | Bevacizumab-alone Maintenance Treatment ProgressionSpain
-
Shanghai Zhongshan HospitalUnknownGastric Cancer Surgical Specimens,18-80 Years Old, at Least Two Tumor Tissue Blocks
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative...CompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Stage IV Breast CancerUnited States
-
Alain AlgaziGenentech, Inc.RecruitingCarcinoma | Cancer | Head and Neck Cancer | Squamous Cell CarcinomaUnited States
-
Hunan Province Tumor HospitalCompletedExtensive Stage Small Cell Lung CancerChina
-
Washington University School of MedicineEli Lilly and Company; ImmunityBio, Inc.WithdrawnNSCLC | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Carcinoma